These results indicate that following COX6A2 knockout, KO cardiomyocytes exhibited obvious metabolic disorders in fatty acid and glucose metabolism pathways, and the energy supply of cardiomyocytes is insufficient, which is consistent with the pathological phenotype of myocardial remodeling. The gene discussed is COX6A2; the disease is metabolic disease.